Michael Hust

Author PubWeight™ 38.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation. Antimicrob Agents Chemother 2007 1.27
2 Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity. BMC Biotechnol 2009 1.19
3 Towards proteome scale antibody selections using phage display. N Biotechnol 2009 1.15
4 High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells. BMC Biotechnol 2013 1.13
5 Minimum information about a protein affinity reagent (MIAPAR). Nat Biotechnol 2010 1.10
6 On the influence of vector design on antibody phage display. J Biotechnol 2006 1.07
7 Expression of recombinant antibodies. Front Immunol 2013 1.06
8 Generating recombinant antibodies to the complete human proteome. Trends Biotechnol 2010 1.04
9 Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV). BMC Biotechnol 2008 1.03
10 Perspectives for systematic in vitro antibody generation. Gene 2005 1.00
11 Phage display derived therapeutic antibodies. Curr Pharm Biotechnol 2008 1.00
12 Rise and fall of an anti-MUC1 specific antibody. PLoS One 2011 0.99
13 SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. N Biotechnol 2008 0.98
14 Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus. PLoS One 2009 0.98
15 Production systems for recombinant antibodies. Front Biosci 2008 0.96
16 Phage display for the generation of antibodies for proteome research, diagnostics and therapy. Molecules 2011 0.96
17 Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo. PLoS One 2012 0.92
18 Affinity maturation by phage display. Methods Mol Biol 2009 0.91
19 Obtention and engineering of non-human primate (NHP) antibodies for therapeutics. Mini Rev Med Chem 2009 0.90
20 Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 2014 0.89
21 Identification of immunogenic polypeptides from a Mycoplasma hyopneumoniae genome library by phage display. Appl Microbiol Biotechnol 2008 0.88
22 Efficient production of soluble recombinant single chain Fv fragments by a Pseudomonas putida strain KT2440 cell factory. Microb Cell Fact 2011 0.87
23 Isolation of scFv fragments specific to OmpD of Salmonella Typhimurium. Vet Microbiol 2010 0.86
24 Production of single chain Fab (scFab) fragments in Bacillus megaterium. Microb Cell Fact 2007 0.85
25 Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display. BMC Biotechnol 2012 0.85
26 Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin. BMC Biotechnol 2011 0.85
27 Phage display-based identification and potential diagnostic application of novel antigens from Mycoplasma mycoides subsp. mycoides small colony type. Vet Microbiol 2009 0.84
28 Suppression of p75 neurotrophin receptor surface expression with intrabodies influences Bcl-xL mRNA expression and neurite outgrowth in PC12 cells. PLoS One 2012 0.84
29 Construction of human antibody gene libraries and selection of antibodies by phage display. Methods Mol Biol 2010 0.83
30 Production of single chain fragment variable (scFv) antibodies in Escherichia coli using the LEX™ bioreactor. J Biotechnol 2012 0.82
31 Production of recombinant antibody fragments in Bacillus megaterium. Microb Cell Fact 2007 0.82
32 Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library. Eur J Immunol 2012 0.81
33 Oligomeric forms of single chain immunoglobulin (scIgG). MAbs 2010 0.81
34 Oligopeptide m13 phage display in pathogen research. Viruses 2013 0.81
35 Influence of the hydromechanical stress and temperature on growth and antibody fragment production with Bacillus megaterium. Appl Microbiol Biotechnol 2011 0.80
36 The influence of antibody fragment format on phage display based affinity maturation of IgG. MAbs 2014 0.80
37 A methodological approach to investigate steady state fucoxanthin chlorophyll a/c binding protein mRNA levels in Wadden Sea sediments. Int Microbiol 2003 0.80
38 Encapsulation of proteins in hydrogel carrier systems for controlled drug delivery: influence of network structure and drug size on release rate. J Biotechnol 2012 0.78
39 Antibody production in Bacillus megaterium: strategies and physiological implications of scaling from microtiter plates to industrial bioreactors. Biotechnol J 2011 0.78
40 Recombinant antibody fragments allow repeated measurements of C-reactive protein with a quartz crystal microbalance immunosensor. MAbs 2012 0.77
41 Human antibodies targeting CD30(+) lymphomas. Hum Antibodies 2012 0.77
42 Antibody production by the gram-positive bacterium Bacillus megaterium. Methods Mol Biol 2009 0.75
43 Linear Discriminant Analysis Identifies Mitochondrially Localized Proteins in Neurospora crassa. J Proteome Res 2015 0.75